Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
- Type
- Expression of concern
- Notice date
- 8/1/2018 0:00
- Journal
- npj Precision Oncology
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41698-018-0062-1
- Original paper DOI
- 10.1038/s41698-017-0008-z
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Image
- Lack of Approval from Author
- Updated to Retraction